news
Petrovax Pharm launches Polyoxidonium® in drops
The new form has been developed for the convenient treatment and prevention of ARVI, influenza, and ENT diseases in adults and children aged 6 months and older
Camrelizumab in combination with paclitaxel and cisplatin can become a new standard of first-line therapy in patients with advanced or metastatic esophageal cancer
Sechenov University and Petrovax Pharm team up to increase access to innovative domestic medicines
Double punch to cancer
Moscow Region Government and Petrovax Pharm sign cooperation agreement
U.S. Geneticist Who Developed Enzyme Replacement Therapy for Fabry Disease Endorses the Russian Biosimilar Fabagal®
Experts predict more novel biotech drug launches in Russia’s market
Russian patients get access to first immuno-oncology drug to treat nasopharyngeal cancer
Board of Experts: iron deficiency anemia is a hidden danger for women and the elderly
